Previous Page  19 / 41 Next Page
Information
Show Menu
Previous Page 19 / 41 Next Page
Page Background

Volume 6, Issue 4 (Suppl)

Clin Pharmacol Biopharm, an open access journal

ISSN: 2167-065X

Page 73

Euro Biopharma & Ethnopharmacology 2017

November 09-11, 2017

&

6

th

International Conference and Exhibition on

November 09-11, 2017 Vienna, Austria

4

th

EUROPEAN BIOPHARMA CONGRESS

PHARMACOLOGY AND ETHNOPHARMACOLOGY

Joint Event

Evaluation of medicine distribution, regulatory privatisation, social welfare services and its alternatives

Abdeen Omer

Occupational Health Administration, Ministry of Health, Sudan

T

he strategy of price liberalisation and privatisation had been implemented in Sudan over the last decade, and has had a

positive result on government deficit. The investment law approved recently has good statements and rules on the above

strategy in particular to pharmacy regulations. Under the pressure of the new privatisation policy, the government introduced

radical changes in the pharmacy regulations. To improve the effectiveness of the public pharmacy, resources should be switched

towards areas of need, reducing inequalities and promoting better health conditions. Medicines are financed either through

cost sharing or full private and the role of the private services is significant. A review of reform of financing medicines in Sudan

is given in this article. Also, it highlights the current drug supply system in the public sector, which is currently responsibility of

the Central Medical Supplies Public Corporation (CMS). In Sudan, the researchers did not identify any rigorous evaluations or

quantitative studies about the impact of drug regulations on the quality of medicines and how to protect public health against

counterfeit or low-quality medicines, although it is practically possible. However, the regulations must be continually evaluated

to ensure the public health is protected against by marketing high quality medicines rather than commercial interests, and the

drug companies are held accountable for their conducts.

abdeenomer2@yahoo.co.uk

Clin Pharmacol Biopharm 2017, 6:4(Suppl)

DOI: 10.4172/2167-065X-C1-026